Insider Transactions in Q1 2022 at Tandem Diabetes Care Inc (TNDM)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 16
2022
|
David B Berger EVP & Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,000
-51.46%
|
$540,000
$108.37 P/Share
|
|
Mar 16
2022
|
David B Berger EVP & Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+33.97%
|
$90,000
$18.86 P/Share
|
|
Mar 14
2022
|
Kathleen Mc Groddy Goetz Director |
SELL
Open market or private sale
|
Direct |
405
-33.22%
|
$42,930
$106.0 P/Share
|
|
Mar 01
2022
|
David B Berger EVP & Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,000
-17.49%
|
$112,000
$112.68 P/Share
|
|
Mar 01
2022
|
David B Berger EVP & Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+14.89%
|
$18,000
$18.86 P/Share
|
|
Feb 28
2022
|
Elizabeth Anne Gasser EVP, Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
153
-19.05%
|
$17,136
$112.43 P/Share
|
|
Feb 28
2022
|
Elizabeth Anne Gasser EVP, Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
372
+31.66%
|
-
|
|
Feb 28
2022
|
James Leal Chief Manufacturing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
148
-3.43%
|
$16,576
$112.43 P/Share
|
|
Feb 28
2022
|
James Leal Chief Manufacturing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
310
+6.7%
|
-
|
|
Feb 28
2022
|
John F Sheridan PRESIDENT & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
284
-3.62%
|
$31,808
$112.43 P/Share
|
|
Feb 28
2022
|
John F Sheridan PRESIDENT & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
819
+9.46%
|
-
|
|
Feb 28
2022
|
Leigh Vosseller EVP & CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
138
-2.04%
|
$15,456
$112.43 P/Share
|
|
Feb 28
2022
|
Leigh Vosseller EVP & CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
407
+5.68%
|
-
|
|
Feb 28
2022
|
Brian B Hansen EVP & CHIEF COMMERCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
146
-2.1%
|
$16,352
$112.43 P/Share
|
|
Feb 28
2022
|
Brian B Hansen EVP & CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
407
+5.53%
|
-
|
|
Feb 28
2022
|
Susan Morrison EVP & Chief Admin. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
114
-1.31%
|
$12,768
$112.43 P/Share
|
|
Feb 28
2022
|
Susan Morrison EVP & Chief Admin. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
407
+4.46%
|
-
|
|
Feb 28
2022
|
David B Berger EVP & Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
141
-2.9%
|
$15,792
$112.43 P/Share
|
|
Feb 28
2022
|
David B Berger EVP & Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
407
+7.73%
|
-
|
|
Feb 01
2022
|
David B Berger EVP & Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,000
-6.52%
|
$117,000
$117.78 P/Share
|
|
Feb 01
2022
|
David B Berger EVP & Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+15.5%
|
$18,000
$18.86 P/Share
|
|
Feb 01
2022
|
Rebecca B Robertson Director |
SELL
Open market or private sale
|
Direct |
1,500
-58.53%
|
$175,500
$117.78 P/Share
|
|
Feb 01
2022
|
Rebecca B Robertson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+50.0%
|
$51,000
$34.0 P/Share
|
|
Jan 04
2022
|
Rajwant Sodhi Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,069
+50.0%
|
-
|
|
Jan 03
2022
|
David B Berger EVP & Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,000
-9.45%
|
$149,000
$149.65 P/Share
|
|
Jan 03
2022
|
David B Berger EVP & Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+15.5%
|
$18,000
$18.86 P/Share
|